CBX5
| | | [1]
|---|---| [2]
| Full Name | Chromobox Protein Homolog 5 | [3]
| Gene Symbol | CBX5 | [4]
| Aliases | HP1α, HP1A, HP1 | [5]
| Chromosome | 12q13.13 | [6]
| Gene Type | Protein-coding | [7]
| OMIM | 604478 | [8]
| UniProt | P45973 |
| HGNC | 1555 |
| Entrez Gene | 23468 |
| Ensembl | ENSG00000094916 |
CBX5 is a human gene. Variants in CBX5 have been implicated in Alzheimer's Disease, Parkinson's Disease, Aging and Senescence. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
CBX5 (Chromobox Protein Homolog 5), commonly known as HP1α (Heterochromatin Protein 1 alpha), encodes a non-histone chromosomal protein that recognizes and binds methylated histone H3 lysine 9 (H3K9me2/3). HP1α is a fundamental component of constitutive heterochromatin, functioning as a reader of H3K9 methylation marks deposited by SETDB1 and SUV39H1. In the nervous system, CBX5/HP1α maintains genomic stability, silences repetitive elements, and regulates neuronal gene expression. Age-related loss of HP1α is a hallmark of cellular senescence and has been linked to heterochromatin erosion in Alzheimer's disease and other neurodegenerative disorders.
CBX5/HP1α contains two conserved domains: an N-terminal chromodomain (CD) that binds H3K9me2/3, and a C-terminal chromoshadow domain (CSD) that mediates homodimerization and interactions with effector proteins. The hinge region between these domains binds DNA and RNA, contributing to chromatin compaction and phase separation.
HP1α is essential for constitutive heterochromatin at pericentromeric regions, telomeres, and transposable elements. Upon binding H3K9me3 via its chromodomain, HP1α recruits SUV39H1 to methylate adjacent nucleosomes, creating a self-propagating heterochromatin spreading mechanism. This read-write cycle maintains the epigenetic silencing of repetitive sequences and prevents transposon mobilization. In neurons, HP1α-dependent heterochromatin integrity is essential for genomic stability throughout the postmitotic lifespan (Larson et al., 2017).
HP1α undergoes liquid-liquid phase separation (LLPS) to form heterochromatin droplets that exclude transcriptional machinery. This biophysical mechanism creates distinct nuclear compartments that physically separate active and silent chromatin domains. In neurons, HP1α phase separation dynamics are modulated by neuronal activity — depolarization triggers HP1α redistribution from heterochromatin foci, transiently opening chromatin for activity-dependent gene expression.
HP1α cooperates with SETDB1 and the HUSH (Human Silencing Hub) complex to silence LINE-1 retrotransposons, Alu elements, and endogenous retroviruses. In the brain, LINE-1 retrotransposition is normally active at low levels during neurogenesis, contributing to somatic mosaicism. HP1α limits this transposition to prevent pathological genomic instability. Age-related HP1α decline leads to excessive retrotransposition and accumulation of toxic retrotransposon RNA and protein products.
HP1α is rapidly recruited to DNA double-strand breaks (DSBs), where it facilitates chromatin remodeling around damage sites and promotes homologous recombination repair. HP1α also maintains telomere integrity by protecting telomeric chromatin structure. In aging neurons, declining HP1α levels compromise both DSB repair and telomere maintenance.
Heterochromatin erosion is an early and progressive feature of AD. HP1α protein levels are significantly reduced in AD hippocampal neurons, correlating with loss of H3K9me3 and de-repression of normally silenced genomic regions. This heterochromatin relaxation leads to aberrant transcription of repetitive elements, activation of innate immune sensors (cGAS-STING pathway), and chronic neuroinflammatory signaling. Tau pathology directly drives HP1α loss — pathological tau displaces HP1α from chromatin through direct interaction with heterochromatin domains (Frost et al., 2014).
In PD dopaminergic neurons, HP1α redistribution from pericentromeric heterochromatin precedes neuronal death. α-Synuclein oligomers impair HP1α nuclear localization by disrupting nuclear import machinery. Loss of HP1α-mediated heterochromatin in PD neurons activates retrotransposon expression and DNA damage accumulation.
HP1α decline is a conserved hallmark of cellular aging across species. In the aging brain, progressive loss of HP1α leads to heterochromatin decompaction, increased LINE-1 expression, and activation of the senescence-associated secretory phenotype (SASP) in aged neurons and astrocytes. This contributes to the chronic low-grade neuroinflammation observed in the aged brain.
In this accelerated aging syndrome caused by lamin A mutations, HP1α is mislocalized due to disrupted nuclear lamina-heterochromatin interactions. The resulting heterochromatin loss phenocopies many features of age-related neurodegeneration, providing a direct link between HP1α dysfunction and premature neural aging.
CBX5/HP1α is ubiquitously expressed with particularly high levels in the brain, especially in postmitotic neurons that must maintain heterochromatin throughout their lifespan. Within the CNS, highest expression is observed in hippocampal CA1/CA3 pyramidal neurons, cortical neurons, cerebellar Purkinje cells, and substantia nigra dopaminergic neurons — notably the populations most vulnerable to neurodegeneration. Expression progressively declines with age, with accelerated loss in neurodegenerative disease.
| Variant | Type | Association | Reference |
|---|---|---|---|
| rs10849527 | Intronic | eQTL for CBX5 expression in brain tissue | GTEx Consortium, 2020 |
| rs7978028 | Promoter | Altered HP1α expression in aging cortex | Zhang et al., 2015 |
| rs1180553 | Intronic | Nominal association with cognitive decline | IGAP, 2019 |
Restoring HP1α function represents a novel therapeutic strategy for age-related neurodegeneration:
Bannister et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain (2001). 2001. ↩︎
Lachner et al. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (2001). 2001. ↩︎
Strom et al. Phase separation drives heterochromatin domain formation (2017). 2017. ↩︎
De Cecco et al. L1 drives IFN in senescent cells and promotes age-associated inflammation (2019). 2019. ↩︎
Zhang et al. Aging stem cells: a Werner syndrome model links epigenetics to stem cell exhaustion (2015). 2015. ↩︎
Shumaker et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging (2006). 2006. ↩︎
Saksouk et al. Constitutive heterochromatin formation and transcription in mammals (2015). 2015. ↩︎
Canzio et al. Chromodomain-mediated oligomerization of HP1 suggests a nucleosome-bridging mechanism for heterochromatin assembly (2011). 2011. ↩︎